Abstract
Second solid tumors are well known late complications after bone marrow transplantation. Treatment strategies are ill defined. We retrospectively evaluated treatment and outcome in a single institution. From August 1974 to July 1996, six solid tumors were observed in five of 387 patients 2 to 13 years after BMT, corresponding to a probability of developing a second solid tumor of 9% (1–17%, 95 CI) at 15 years: these comprised endometrial carcinoma, carcinoma of the thyroid gland, cervical carcinoma, sarcoma of the small intestine, osteosarcoma of the tibia and ovarian carcinoma. All five patients were treated as intensively as they would be without a history of BMT. At last follow-up four of the five patients were alive and without signs of tumor. We postulate that second solid tumors after BMT should be treated as de novo tumors. Early detection based on consequent clinical follow-up of the transplant patients might explain the relatively good outcome. Bone Marrow Transplantation (2000) 25, 895–898.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Armitage J . Bone marrow transplantation New Engl J Med 1994 330: 827–838
Schmitz N, Gratwohl A, Goldman JM et al. Guidelines for allogeneic and autologous transplantation in haematological diseases, solid tumors and immune disorders Bone Marrow Transplant 1996 17: 471–477
Bhatia S, Ramsay NK, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation Blood 1996 87: 3633–3639
Tichelli A, Gratwohl A, Uhr M et al. Gesundheitszustand und Spätkomplikationen nach allogener Knochenmarktransplantation Schweiz Med Wschr 1991 121: 1473–1481
Shapiro RS, McClain K, Frizzera G et al. Epstein–Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation Blood 1988 71: 1234–1243
Socié G, Henry-Amar M, Devergie A et al. Malignant diseases after allogeneic bone marrow transplantation: an updated overview Nouv Rev Fr Hemtol 1994 36: (Suppl.I) 75–77
Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia New Engl J Med 1989 321: 784–789
Kolb HJ, Duell T, Socié G et al. New malignancies in patients surviving more than 5 years after marrow transplantation Blood 1995 86: (Suppl.1) 460a (Abstr.)
Papadopoulos EB, Ladanyi M, Emmanuel D et al. Infusions of donor leukocytes to treat Epstein–Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation New Engl J Med 1994 330: 1185–1191
Deeg HJ, Socié G . Malignancies after hematopoietic stem cell transplantation: many questions, some answers Blood 1998 91: 1833–1844
Speck B, Gratwohl A, Tichelli A, Nissen C . Knochenmark-transplantation Schweiz Med Wschr 1995 125: 1515–1532
Socié G, Henry-Amar M, Cosset JM et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia Blood 1991 78: 277–279
Deeg HJ, Socié G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris Analysis of results in 700 patients Blood 1996 87: 386–392
Atree SV, Crilley PA, Conroy JF et al. Cancer of the esophagus following allogeneic bone marrow transplantation for acute leukemia Am J Clin Oncol 1995 18: 343–347
Socié G, Henry-Amar M, Devergie A et al. Poor clinical outcome of patients developing malignant solid tumors after bone marrow transplantation for severe aplastic anemia Leuk Lymphoma 1992 7: 419–423
Curtis RE, Rowlings PA, Deeg HJ et al. Solid cancer after bone marrow transplantation New Engl J Med 1997 336, 13: 897–904
Lishner M, Patterson B, Kandel R et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients Cancer 1990 65: 473–476
Acknowledgements
This work was supported in part by the Swiss National Research Foundation, the Swiss Cancer league and the Swiss Foundation for Cancer Research No. 32–52756.97.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Favre-Schmuziger, G., Hofer, S., Passweg, J. et al. Treatment of solid tumors following allogeneic bone marrow transplantation. Bone Marrow Transplant 25, 895–898 (2000). https://doi.org/10.1038/sj.bmt.1702339
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702339
Keywords
This article is cited by
-
Three resected cases of esophageal carcinoma considered as being secondary solid tumors after bone marrow transplantation
Surgical Case Reports (2021)
-
Esophagectomy for the patients with squamous cell carcinoma of the esophagus after allogeneic hematopoietic stem cell transplantation
International Journal of Clinical Oncology (2020)
-
Granulocyte colony-stimulating factor-producing esophageal squamous cell carcinoma following chemoradiotherapy and bone marrow transplantation for acute lymphoblastic leukemia
Esophagus (2013)
-
Secondary solid tumors after allogeneic hematopoietic SCT in Japan
Bone Marrow Transplantation (2012)
-
Die Schilddrüse nach Stammzelltransplantation im Kindes- und Jugendalter
Monatsschrift Kinderheilkunde (2007)